116 related articles for article (PubMed ID: 38466338)
21. LASS2 suppresses metastasis in multiple cancers by regulating the ferroptosis signalling pathway through interaction with TFRC.
Huang Y; Du J; Li D; He W; Liu Z; Liu L; Yang X; Cheng X; Chen R; Yang Y
Cancer Cell Int; 2024 Feb; 24(1):87. PubMed ID: 38419028
[TBL] [Abstract][Full Text] [Related]
22. Cinobufotalin Induces Ferroptosis to Suppress Lung Cancer Cell Growth by lncRNA LINC00597/hsa-miR-367-3p/TFRC Pathway via Resibufogenin.
Huang J; Deng C; Guo T; Chen X; Chen P; Du S; Lu M
Anticancer Agents Med Chem; 2023; 23(6):717-725. PubMed ID: 36221890
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
[TBL] [Abstract][Full Text] [Related]
24. A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner.
Wang J; Xu J; Zheng J
Sci Rep; 2023 Nov; 13(1):20730. PubMed ID: 38007504
[TBL] [Abstract][Full Text] [Related]
25. Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas.
Jiang XP; Elliott RL; Head JF
Anticancer Res; 2010 Mar; 30(3):759-65. PubMed ID: 20392994
[TBL] [Abstract][Full Text] [Related]
26. [Screening the differential expression of adriamycin-resistance related genes of breast cancer by cDNA microarray].
Peng H; Yang HW; Song LW; Zhou Z
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1745-8. PubMed ID: 19862977
[TBL] [Abstract][Full Text] [Related]
27. Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway.
Huang Q; Wu YY; Xing SJ; Yu ZW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5285-5292. PubMed ID: 31298380
[TBL] [Abstract][Full Text] [Related]
28. Ferroptosis is critical for phthalates driving the blood-testis barrier dysfunction via targeting transferrin receptor.
Zhao Y; Zhang H; Cui JG; Wang JX; Chen MS; Wang HR; Li XN; Li JL
Redox Biol; 2023 Feb; 59():102584. PubMed ID: 36580806
[TBL] [Abstract][Full Text] [Related]
29. Glutathione S-transferases P1 protects breast cancer cell from adriamycin-induced cell death through promoting autophagy.
Dong X; Yang Y; Zhou Y; Bi X; Zhao N; Zhang Z; Li L; Hang Q; Zhang R; Chen D; Cao P; Yin Z; Luo L
Cell Death Differ; 2019 Oct; 26(10):2086-2099. PubMed ID: 30683915
[TBL] [Abstract][Full Text] [Related]
30. microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2.
Zeng H; Wang L; Wang J; Chen T; Li H; Zhang K; Chen J; Zhen S; Tuluhong D; Li J; Wang S
Arch Biochem Biophys; 2018 Aug; 651():52-60. PubMed ID: 29802821
[TBL] [Abstract][Full Text] [Related]
31. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J
Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
33. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
[TBL] [Abstract][Full Text] [Related]
34. Combination of 7-
Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y
Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024
[TBL] [Abstract][Full Text] [Related]
35. METTL3 attenuates ferroptosis sensitivity in lung cancer via modulating TFRC.
Zhang P; Wang S; Chen Y; Yang Q; Zhou J; Zang W
Open Med (Wars); 2024; 19(1):20230882. PubMed ID: 38221933
[TBL] [Abstract][Full Text] [Related]
36. Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15.
Ballaré C; Portela P; Schiaffi J; Yomha R; Mordoh J
Breast Cancer Res Treat; 1998 Jan; 47(2):163-70. PubMed ID: 9497104
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of miRNA-452 is associated with adriamycin-resistance in breast cancer cells.
Hu Q; Gong JP; Li J; Zhong SL; Chen WX; Zhang JY; Ma TF; Ji H; Lv MM; Zhao JH; Tang JH
Asian Pac J Cancer Prev; 2014; 15(13):5137-42. PubMed ID: 25040964
[TBL] [Abstract][Full Text] [Related]
38. Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors.
Zhuang C; Li X; Yang L; Ma X; Shen Y; Huang C; Pan T; Cui J; Ni B; Wang M
Front Oncol; 2023; 13():1151687. PubMed ID: 37675227
[TBL] [Abstract][Full Text] [Related]
39. Development of a complete human anti-human transferrin receptor C antibody as a novel marker of oral dysplasia and oral cancer.
Nagai K; Nakahata S; Shimosaki S; Tamura T; Kondo Y; Baba T; Taki T; Taniwaki M; Kurosawa G; Sudo Y; Okada S; Sakoda S; Morishita K
Cancer Med; 2014 Aug; 3(4):1085-99. PubMed ID: 24890018
[TBL] [Abstract][Full Text] [Related]
40. Exosomes derived from hepatitis B virus-infected hepatocytes promote liver fibrosis via miR-222/TFRC axis.
Zhang Q; Qu Y; Zhang Q; Li F; Li B; Li Z; Dong Y; Lu L; Cai X
Cell Biol Toxicol; 2023 Apr; 39(2):467-481. PubMed ID: 34978008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
